Llwytho...
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses
BACKGROUND: High-dose short-term methylprednisolone is the recommended treatment in the management of multiple sclerosis relapses, although it has been suggested that lower doses may be equally effective. Also, glucocorticoids are associated with multiple and often dose-dependent adverse effects. Th...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | BMC Neurol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BioMed Central
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4609048/ https://ncbi.nlm.nih.gov/pubmed/26475456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-015-0450-x |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|